🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsPublic SquareNovo Nordisk CagriSema Phase 3 results — amylin + GLP-1 Page 3

Novo Nordisk CagriSema Phase 3 results — amylin + GLP-1

TrialTracker_MD Sat, Jun 6, 2026 at 4:45 AM 14 replies 338 viewsPage 3 of 3
PedsEndoPhilly
Member
345
1,890
Jun 2024
Philadelphia, PA
Jun 6, 2026 at 5:51 PM#11
chris_chi24 said:
Relative and absolute effects need reading together.

Genuinely useful, thank you. I had the facts and not the framework. Adding it to my notes with a link back to this thread.

16 16sarah_TO, wendy_avl, jason_paloalto and 13 others
Reply Quote Save Share Report
Dr.DermMIA
Member
456
2,123
May 2024
Miami, FL
Jun 7, 2026 at 6:02 AM#12

Clinical perspective, offered as context rather than as advice. The mechanism and the magnitude are separate questions. Agreeing that something happens says nothing about whether it happens enough to act on.

Last edited: Jun 7, 2026 at 8:02 AM
15 15Dr.RenalNash, LipidDoc_ATL, BariatricNurseD and 12 others
Reply Quote Save Share Report
Dr.GutHealth
Senior Member
1,456
7,890
Mar 2024
Minnesota
Jun 7, 2026 at 6:13 PM#13
Dr.Martinez said:
The gap between trial results and real-world results is consistent and it is not fraud.

Filing a mild objection. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit. I would add the less popular caveat: these trial populations under-represented several groups, older adults and the highest BMI categories among them. The results probably generalise, and "probably" should be stated as an assumption rather than dropped.

Last edited: Jun 7, 2026 at 11:13 PM
14 14jennifer_SEA, tyler_CSCS, VanRx_Mike and 11 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
Dr.NateNeph
VIP Member
2,987
16,234
Dec 2023
Houston, TX
Jun 8, 2026 at 6:25 AM#14

Adding the numbers, since they settle part of this. Keep the original post as written when you update it, and add the correction underneath. An edited-away mistake is invisible to the next person who makes it.

13 13B12Beth, RickReta_CO, PharmHunterJen and 10 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Jun 8, 2026 at 6:37 PM#15

Moderator note: reminder that nothing in this thread is medical advice, and that clinical claims need a source. Report rather than reply if it drifts again.

12 12PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 9 others
Reply Quote Save Share Report

Similar Threads

SELECT trial 4-year follow-up data released — sustained MACE reduction16 replies
GLP-1 receptor agonists and thyroid C-cell concerns — evidence review19 replies
Is there a ceiling effect for GLP-1-mediated weight loss?20 replies
Comparative pharmacokinetics: semaglutide vs tirzepatide vs retatrutide6 replies
My 18-month semaglutide journey — comprehensive data log20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register